Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.69 (
botulinum neurotoxin
)
1,901
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
There have been several outbreaks of botulism among poultry and wild birds in Sweden in recent years. The National Veterinary Institute of Sweden (SVA) has identified
botulinum neurotoxin
(
BoNT
)/C1 or the mosaic
BoNT
/
C1D
using the mouse bioassay. This is believed to be the first report on the application of the Endopep mass spectrometry (Endopep-MS) method to selected clinical animal (serum and liver) samples and a feed sample that had previously given positive test results with the mouse bioassay. In the mouse bioassay eight of the eleven samples were found to be neutralized by both
BoNT
/C1 and /D antitoxins; the other three were neutralized only by
BoNT
/C1 antitoxin, but the mice showed a prolonged survival time when the samples had been treated with /D antitoxin. The Endopep-MS analysis, on the other hand, demonstrated only
BoNT
/C1 activity for all eleven samples. This suggests that at least eight of the samples were of the chimeric toxin type
BoNT
/
C1D
, where the enzymically active site is identical to that of
BoNT
/C1, while other parts of the protein contain sequences of
BoNT
/D. This is the first step of a cross-validation between the established mouse bioassay and the Endopep-MS of serotypes
BoNT
/C1 and /
C1D
. Endopep-MS is concluded to have potential as an attractive alternative to the mouse bioassay.
...
PMID:Confirmation of botulism in birds and cattle by the mouse bioassay and Endopep-MS. 2156 90